Oxidative LDL modification is increased in vascular dementia and is inversely associated with cognitive performance

References

• Fenech M. The role of folic acid and Vitamin B12 in genomic stability of human cells. Mutat Res 2001;475:57–67.
   PubMed Web of Science ®Google Scholar
• Cravo M. Alcohol, methylenetetrahydrofolate 677C->T genotype, and low folate intake: concurrent causes for hyperhomocysteinemia, Am J Clin Nutr 2005;82:3–4.
   Google Scholar
• Lievers KJA, Kluijtmans LAJ, Blom HJ. Genetics of hyperhomocysteinaemia in cardiovascular disease. Ann Clin Biochem 2003;40:46–59.
   PubMedGoogle Scholar
• Selhub J. The many facets of hyperhomocysteinemia: studies from the Framingham cohorts. J Nutr 2006;136:1726S–1730S.
   PubMed Web of Science ®Google Scholar
• Seshadri S. Elevated plasma homocysteine levels: risk factor or risk marker for the development of dementia and Alzheimer's disease? J Alzheimer's Dis 2006;9:393–398.
   PubMed Web of Science ®Google Scholar
• De Deyn PP, Goeman J, Engelborghs S, Hauben U, D'Hooge R, Baro F, Pickut BA. From neuronal and vascular impairment to dementia. Pharmacopsychiatry 1999;32(Suppl 1):17–24.
   Google Scholar
• Scott TM, Tucker KL, Bhadelia A, Benjamin B, Patz S, Bhadelia R, Liebson E, Price LL, Griffith J, Rosenberg I, Folstein MF. Homocysteine and B vitamins relate to brain volume and white-matter xhanges in geriatric patients with psychiatric disorders. Am J Geriatr Psychiatry 2004;12:631–638.
   PubMed Web of Science ®Google Scholar
• Griffiths HR, Møller L, Bartosz G, Bast A, Bertoni-Freddari C, Collins A, Cooke M, Coolen S, Haenen G, Hoberg AM, Loft S, Lunec J, Olinski R, Parry J, Pompella A, Poulsen H, Verhagen H, Astley SB. Biomarkers. Molec Asp Med 2002;23:101–208.
   PubMedGoogle Scholar
• Nakano E, Taiwo FA, Nugent D, Griffiths HR, Aldred S, Paisi M, Kwok M, Bhatt P, Hill MHE, Moat S, Powers HJ. Downstream effects on human low density lipoprotein of homo-cysteine exported from endothelial cells in an in vitro system. J Lipid Res 2005;46:484–493.
   Google Scholar
• Papatheodorou L, Weiss N. Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antiox Redox Signal 2007;9:1941–1958.
   Google Scholar
• Cacabelos R, Fernandez-Novoa L, Corzo L, Amado L, Pichel V, Lombardi V, Kubota Y. Phenotypic profiles and functional genomics in Alzheimer's disease and in dementia with a vascular component. Neurol Res 2004;26:459–480.
   PubMed Web of Science ®Google Scholar
• Stojakovic T, Scharnagl H, Marz W. ApoE: crossroads between Alzheimer's disease and atherosclerosis. Semin Vasc Med 2004;4:279–285.
   Google Scholar
• Ravaglia G, Paola F, Maioli F, Martelli M, Montesi F, Bastagli L, Bianchin M, Chiappelli M, Tumini E, Bolondi L, Licastro F. Interleukin-1[beta] and interleukin-6 gene polymorphisms as risk factors for AD: a prospective study. Exp Gerontol 2006;41:85–92.
   Google Scholar
• Gil L, Siems W, Mazurek B, Gross J, Schroeder P, Voss P, Grune T. Age-associated analysis of oxidative stress parameters in human plasma and erthrocytes. Free Radic Res 2006;40:495–505.
   PubMed Web of Science ®Google Scholar
• Griffiths HR. Chemical modifications of biomolecules by oxidants. In: The handbook of environmental chemistry. Reactions, processes. Ed. Tilman Grune. Berlin: Springer; 2005. 33–62.
   Google Scholar
• Polidori MC, Griffiths HR, Mariani E, Mecocci P. Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease. Amino Acids 2007;32:553–559.
   PubMed Web of Science ®Google Scholar
• Reddy VP, Zhu X, Perry G, Smith MA. Oxidative stress in diabetes and Alzheimer's disease. J Alzheimers Dis 2009;16:763–774.
   PubMed Web of Science ®Google Scholar
• Moreira PI, Duarte AI, Santos MS, Rego AC, Oliveira CR. An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease. J Alzheimers Dis 2009;16:741–761.t
   PubMed Web of Science ®Google Scholar
• Mangialasche F, Polidori MC, Monastero R, Ercolani S, Camarda C, Cecchetti R, Mecocci P. Biomarkers of oxidative and nitro sative damage in Alzheimer's disease and mild cognitive impairment. Ageing Res Rev 2009;8:285–305.
   PubMed Web of Science ®Google Scholar
• Griffiths HR, Aldred S, Dale C, Nakano E, Kitas GD, Grant MM, Nugent D, Taiwo FA, Li L, Powers J. Homocysteine from endothelial cells promotes LDL nitration and scavenger receptor uptake. Free Radic Biol Med 2006;40:488–500.
   PubMed Web of Science ®Google Scholar
• Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985–1992.
   PubMed Web of Science ®Google Scholar
• Anlasik T, Sies H, Griffiths HR, Mecocci P, Stahl W, Polidori MC. Dietary habits are major determinants of the plasma antioxidant status in healthy elderly subjects. Br J Nutr 2005;94:639–642.
   Google Scholar
• Folstein MF, Robins LN, Helzer JE. The mini-mental state examination. Arch Gen Psychiatry 1983;40:812.
   PubMed Web of Science ®Google Scholar
• Clarke R, Refsum H, Birks J, Evans JG, Johnston C, Sherliker P, Ueland PM, Schneede J, McPartlin J, Nexo E, Scott JM. Screening for vitamin B-12 and folate deficiency in older persons. Am J Clin Nutr 2003;77:1241–1247.
   PubMed Web of Science ®Google Scholar
• Terpstra AHM. Isolation of serum chylomicrons prior to density gradient ultracentrifugation of other serum lipoprotein classes. Anal Biochem 1985;150:221–227.
   Google Scholar
• Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76–85.
   PubMed Web of Science ®Google Scholar
• Carty JL, Bevan R, Waller H, Mistry N, Cooke MC, Lunec J, Griffiths HR. The effects of vitamin C supplementation on protein oxidation in healthy volunteers. Biochem Biophys Res Commun 2000;273:729–735.
   PubMed Web of Science ®Google Scholar
• te Poele-Pothoff M, van den Berg M, Franken DG, Boers GH, Jakobs C, de Kroon IF, Eskes TK, Trijbels JM, Blom HJ. Three different methods for the determination of total homo-cysteine in plasma. Ann Clin Biochem 1995;32:218–220.
   PubMedGoogle Scholar
• Watanabe T, Koba S, Kawamura M, Itokawa M, Idei T, Nakagawa Y, Iguchi T, Katagiri T. Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia. Metabolism 2004;3:476–482.
   Google Scholar
• Ohmura H, Mokuno H, Sawano M, Hatsumi C, Mitsugi Y, Watanabe Y, Daida H, Yamaguchi H. Lipid compositional differences of small, dense low-density lipoprotein particle influence its oxidative susceptibility: possible implication of increased risk of coronary artery disease in subjects with phenotype B. Metabolism 2002;51:1081–1087.
   PubMed Web of Science ®Google Scholar
• Navazo MDP, Daviet L, Ninio E, McGregor JL. Identification on human CD36 of a domain (155–183) implicated in binding oxidized low-density lipoproteins (Ox-LDL). Arterioscler Thromb Vasc Biol 1996;16:1033–1039.
   PubMed Web of Science ®Google Scholar
• Shemer R, Walsh A, Eisenberg S, Breslow JL, Razin A. Tissue-specific methylation patterns and expression of the human apolipoprotein AI gene. J Biol Chem 265:1990:1010–1015.
   PubMedGoogle Scholar
• Cramer C, Haan MN, Galea S, Langa KM, Kalbfleisch JD. Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study. Neurology 2008;71:344–350.
   PubMed Web of Science ®Google Scholar
• Li G, Larson EB, Sonnen JA, Shofer JB, Petrie EC, Schantz A, Peskind ER, Raskind MA, Breitner JCS, Montine TJ. Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology 2007;69:878–885.
   PubMed Web of Science ®Google Scholar
• Chauhan NB, Siegel GJ, Feinstein DL. Effects of lovastatin and pravastatin on amyloid processing and inflammatory response in TgCRND8 brain. Neurochem Res 2004;29:1897–1911.
   PubMed Web of Science ®Google Scholar
• McNulty H, Scott JM. Intake and status of folate and related B-vitamins: considerations and challenges in achieving optimal status. Br J Nutr 2008;99(Suppl 3):S48–S54.
   Google Scholar
• Refsum H, Smith AD. Low vitamin B-12 status in confirmed Alzheimer's disease as revealed by serum holotranscobalamin, J Neurol Neurosurg Psychiatry 2003;74:959–961.
   PubMed Web of Science ®Google Scholar